Dr. Gary C. Doolittle
Claim this profileHaysMed University of Kansas Health System
Studies Cancer
Studies Melanoma
18 reported clinical trials
29 drugs studied
Area of expertise
1Cancer
Stage IV
BRAF positive
Stage III
2Melanoma
Stage IV
BRAF positive
Stage III
Affiliated Hospitals
Clinical Trials Gary C. Doolittle is currently running
Brentuximab Vedotin + Pembrolizumab
for Advanced Cancers
This trial will find out whether brentuximab vedotin and pembrolizumab work together to treat different types of cancer. There will be several different types of cancer studied in the trial. The cancer must have spread to other parts of the body (metastatic). The study will also find out what side effects occur. A side effect is anything the treatment does besides treat cancer. This is a multi-cohort study.
Recruiting1 award Phase 27 criteria
Nivolumab + Ipilimumab + Sargramostim
for Advanced Melanoma
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable) and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Colony-stimulating factors, such as sargramostim, may increase the production of white blood cells. It is not yet known whether nivolumab and ipilimumab are more effective with or without sargramostim in treating patients with melanoma.
Recruiting1 award Phase 2 & 323 criteria
More about Gary C. Doolittle
Clinical Trial Related3 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Gary C. Doolittle has experience with
- Nivolumab
- Pembrolizumab
- Ipilimumab
- Chemotherapy
- Relatlimab
- Low Intensity Stepped Care
Breakdown of trials Gary C. Doolittle has run
Cancer
Melanoma
Skin Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gary C. Doolittle specialize in?
Gary C. Doolittle focuses on Cancer and Melanoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are BRAF positive.
Is Gary C. Doolittle currently recruiting for clinical trials?
Yes, Gary C. Doolittle is currently recruiting for 9 clinical trials in Hays Kansas. If you're interested in participating, you should apply.
Are there any treatments that Gary C. Doolittle has studied deeply?
Yes, Gary C. Doolittle has studied treatments such as Nivolumab, Pembrolizumab, Ipilimumab.
What is the best way to schedule an appointment with Gary C. Doolittle?
Apply for one of the trials that Gary C. Doolittle is conducting.
What is the office address of Gary C. Doolittle?
The office of Gary C. Doolittle is located at: HaysMed University of Kansas Health System, Hays, Kansas 67601 United States. This is the address for their practice at the HaysMed University of Kansas Health System.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.